GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) » Definitions » Shiller PE Ratio

Zhejiang Hisun Pharmaceutical Co (SHSE:600267) Shiller PE Ratio : 71.50 (As of Dec. 14, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Zhejiang Hisun Pharmaceutical Co Shiller PE Ratio?

As of today (2024-12-14), Zhejiang Hisun Pharmaceutical Co's current share price is ¥8.58. Zhejiang Hisun Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥0.12. Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio for today is 71.50.

The historical rank and industry rank for Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600267' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.97   Med: 58.59   Max: 100.13
Current: 71.5

During the past years, Zhejiang Hisun Pharmaceutical Co's highest Shiller PE Ratio was 100.13. The lowest was 27.97. And the median was 58.59.

SHSE:600267's Shiller PE Ratio is ranked worse than
88.17% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.8 vs SHSE:600267: 71.50

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Hisun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.12 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Hisun Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Hisun Pharmaceutical Co Shiller PE Ratio Chart

Zhejiang Hisun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.34 85.85 85.99 67.69 86.18

Zhejiang Hisun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.37 86.18 64.34 57.56 70.75

Competitive Comparison of Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio falls into.



Zhejiang Hisun Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=8.58/0.12
=71.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Hisun Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Zhejiang Hisun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.07/115.7848*115.7848
=0.070

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Hisun Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.080 99.000 0.094
201503 0.010 99.900 0.012
201506 0.033 99.500 0.038
201509 -0.030 100.500 -0.035
201512 0.009 100.600 0.010
201603 0.006 102.200 0.007
201606 0.015 101.400 0.017
201609 0.011 102.400 0.012
201612 -0.132 102.600 -0.149
201703 0.007 103.200 0.008
201706 0.007 103.100 0.008
201709 -0.009 104.100 -0.010
201712 0.009 104.500 0.010
201803 0.011 105.300 0.012
201806 0.004 104.900 0.004
201809 -0.008 106.600 -0.009
201812 -0.517 106.500 -0.562
201903 0.033 107.700 0.035
201906 0.022 107.700 0.024
201909 1.245 109.800 1.313
201912 -1.200 111.200 -1.249
202003 -0.074 112.300 -0.076
202006 0.323 110.400 0.339
202009 0.106 111.700 0.110
202012 0.075 111.500 0.078
202103 0.119 112.662 0.122
202106 0.131 111.769 0.136
202109 0.182 112.215 0.188
202112 -0.013 113.108 -0.013
202203 0.110 114.335 0.111
202206 0.150 114.558 0.152
202209 0.010 115.339 0.010
202212 0.140 115.116 0.141
202303 0.170 115.116 0.171
202306 0.150 114.558 0.152
202309 0.030 115.339 0.030
202312 -0.460 114.781 -0.464
202403 0.210 115.227 0.211
202406 0.160 114.781 0.161
202409 0.070 115.785 0.070

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Hisun Pharmaceutical Co  (SHSE:600267) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhejiang Hisun Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Hisun Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Hisun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Executives
Yu Shun Bing Supervisors
Jin Hong Shun senior management
Lu Xing Hai senior management
Zhang Zhen Ying senior management
Jiang Guo Ping Director
Yang Zhi Qing senior management
Du Jia Qiu senior management
Chen Xiao Hua Directors, senior managers
Li Yan Directors, senior managers
Zhao Lei senior management
Shen Xi Fei Director
Zhang Wei senior management
Bai Hua Director
Chen Li Fei Supervisors
Hu Liang Bin senior management

Zhejiang Hisun Pharmaceutical Co Headlines

No Headlines